Mice immunized with variously adjuvanted nanofibers were then studied with a model of psoriasis in which the application of imiquimod leads to epidermal thickening (Figure 6A) mimicking plaque psoriasis in humans in addition to the increase of IL-17 and other inflammatory cytokines. This evidence concerns the gene IL17A and psoriasis vulgaris.